Nikia Lee Frohlich, MS CCC-SLP | |
Mary E Theler Center Nmsd Preschool, 22871 Wa-3, Belfair, WA 98528 | |
(360) 277-2287 | |
Not Available |
Full Name | Nikia Lee Frohlich |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | Mary E Theler Center Nmsd Preschool, Belfair, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811538465 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 14264439 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Nikia Lee Frohlich, MS CCC-SLP Mary E Theler Center Nmsd Preschool, 22871 Wa-3, Belfair, WA 98528 Ph: () - | Nikia Lee Frohlich, MS CCC-SLP Mary E Theler Center Nmsd Preschool, 22871 Wa-3, Belfair, WA 98528 Ph: (360) 277-2287 |
News Archive
In a study published today in the Journal of Experimental Medicine, researchers successfully used a new approach that significantly minimized brain damage caused by stroke in mouse models.
Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.
The human brain is bombarded with all kinds of information, from the memory of last night's delicious dinner to the instructions from your boss at your morning meeting. But how do you "tune in" to just one thought or idea and ignore all the rest of what is going on around you, until it comes time to think of something else?
University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cells, and then to use the new genetic signature to identify currently available drugs that selectively target the rogue cells.
› Verified 8 days ago
Maureen Ann Jones, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 71 E Campus Dr, Belfair, WA 98528 Phone: 360-277-2111 Fax: 360-277-2321 | |
Jody Fletcher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22900 Ne Hwy 3, Belfair, WA 98528 Phone: 360-277-2250 | |
Delaney Kinstner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22900 Ne State Route 3, Belfair, WA 98528 Phone: 360-277-2250 | |
Jessica Suggs, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 71 E Campus Dr, Belfair, WA 98528 Phone: 360-277-2206 |